GlassScriptPhysician profile
Frank A Greathouse
NPI 1780699330
$6,592.09
in general payments reported to CMS, 2019-2025
39 companies · $1,302 in 2025
The $1,302 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $337 · 2020: $916 · 2021: $1,008 · 2022: $1,119 · 2023: $923 · 2024: $987 · 2025: $1,302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,212.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,212.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $957.91 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Abbvie INC. | $881.08 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $814.75 | 2022-2025 | Caplyta |
| Glaxosmithkline, LLC. | $692.67 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Novo Nordisk INC | $488.01 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Allergan, INC. | $271.16 | 2019-2021 | |
| Pfizer INC. | $262.67 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $218.78 | 2019-2023 | Verquvo, Steglujan, Steglatro |
| Lilly USA, LLC | $184.92 | 2019-2024 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $166.37 | 2019-2024 | Xifaxan, Trulance |
| Nestle Healthcare Nutrition INC. | $152.99 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $152.67 | 2022-2025 | |
| Eisai INC. | $137.68 | 2020-2022 | |
| E.R. Squibb & Sons, L.L.C. | $103.14 | 2020-2024 | Eliquis |
| Exact Sciences Corporation | $97.32 | 2023-2024 | Cologuard Collection Kit |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Greathouse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.